Cardinal Health (NYSE:CAH) Earns Overweight Rating from Analysts at Barclays

Barclays initiated coverage on shares of Cardinal Health (NYSE:CAH) in a research report sent to investors on Monday morning, Marketbeat reports. The brokerage issued an overweight rating and a $243.00 price target on the stock.

Several other equities analysts have also commented on CAH. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Evercore ISI increased their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Deutsche Bank Aktiengesellschaft upped their target price on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. Finally, Argus lifted their price target on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $209.00.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $198.24 on Monday. The business’s 50 day simple moving average is $185.10 and its 200 day simple moving average is $166.08. Cardinal Health has a 1 year low of $114.60 and a 1 year high of $214.93. The company has a market capitalization of $47.10 billion, a P/E ratio of 29.90, a P/E/G ratio of 1.44 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company’s revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts anticipate that Cardinal Health will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is 30.77%.

Hedge Funds Weigh In On Cardinal Health

Large investors have recently bought and sold shares of the company. SJS Investment Consulting Inc. increased its stake in shares of Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after buying an additional 150 shares during the period. Jones Financial Companies Lllp grew its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC increased its position in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after acquiring an additional 75 shares during the period. JPL Wealth Management LLC bought a new position in shares of Cardinal Health during the third quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in shares of Cardinal Health during the third quarter worth $31,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.